FDA Import Refusal BNI-0061346-1/101/1F — Glaxo Operations U.K. Ltd.
The FDA refused shipment BNI-0061346-1/101/1F from Glaxo Operations U.K. Ltd. (United Kingdom) on August 30, 2017. The refused product falls under Drugs and Biologics — CLOBETASOL PROPIONATE (GLUCOCORTICOID). Cited charge: 473 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 30, 2017
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 64LCJ67 CLOBETASOL PROPIONATE (GLUCOCORTICOID)
- Charges
- 473